BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu KL, Tsai YM, Lien CT, Kuo PL, Hung AJ. The Roles of MicroRNA in Lung Cancer. Int J Mol Sci. 2019;20. [PMID: 30935143 DOI: 10.3390/ijms20071611] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Fujii Y, Takeshima Y. Inhibition of miR-18a-3p reduces proliferation of mesothelioma cells and sensitizes them to cisplatin. Oncol Lett 2020;19:4161-8. [PMID: 32382354 DOI: 10.3892/ol.2020.11504] [Reference Citation Analysis]
2 Konoshenko MY, Lekchnov EA, Bryzgunova OE, Zaporozhchenko IA, Yarmoschuk SV, Pashkovskaya OA, Pak SV, Laktionov PP. The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms. Diagnostics (Basel) 2020;10:E38. [PMID: 31936850 DOI: 10.3390/diagnostics10010038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
3 Datinska V, Gheibi P, Jefferson K, Yang J, Paladugu S, Dallett C, Voracova I, Foret F, Astier Y. Epitachophoresis is a novel versatile total nucleic acid extraction method. Sci Rep 2021;11:22736. [PMID: 34815497 DOI: 10.1038/s41598-021-02214-1] [Reference Citation Analysis]
4 Perillo A, Agbaje Olufemi MV, De Robbio J, Mancuso RM, Roscigno A, Tirozzi M, Scognamiglio IR. Liquid biopsy in NSCLC: a new challenge in radiation therapy. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00038] [Reference Citation Analysis]
5 Adil MS, Khulood D, Somanath PR. Targeting Akt-associated microRNAs for cancer therapeutics. Biochem Pharmacol 2021;189:114384. [PMID: 33347867 DOI: 10.1016/j.bcp.2020.114384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wang Z, Wu X, Hou X, Zhao W, Yang C, Wan W, Chen L. miR-548b-3p functions as a tumor suppressor in lung cancer. Lasers Med Sci 2020;35:833-9. [DOI: 10.1007/s10103-019-02865-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
7 Alexandre D, Teixeira B, Rico A, Valente S, Craveiro A, Baptista PV, Cruz C. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer. IJMS 2022;23:3330. [DOI: 10.3390/ijms23063330] [Reference Citation Analysis]
8 Wieleba I, Wojas-Krawczyk K, Krawczyk P. Aptamers in Non-Small Cell Lung Cancer Treatment. Molecules 2020;25:E3138. [PMID: 32659994 DOI: 10.3390/molecules25143138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Abolfathi H, Sheikhpour M, Mohammad Soltani B, Fahimi H. The comparison and evaluation of the miR-16, miR-155 and miR-146a expression pattern in the blood of TB and NSCLC patients: A Research paper. Gene Reports 2021;22:100967. [DOI: 10.1016/j.genrep.2020.100967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Rezaei S, Mahjoubin-tehran M, Aghaee-bakhtiari SH, Jalili A, Movahedpour A, Khan H, Moghoofei M, Shojaei Z, R Hamblin M, Mirzaei H. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer. Critical Reviews in Oncology/Hematology 2020;153:103063. [DOI: 10.1016/j.critrevonc.2020.103063] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
11 Dai J, Wang B, Zhao Y, Zuo X, Cui H, Chen X, Liu X. Long Noncoding RNA LINC01426 Sequesters microRNA-519d-5p to Promote Non-Small Cell Lung Cancer Progression by Increasing ETS1 Expression. Cancer Manag Res 2020;12:12697-708. [PMID: 33335425 DOI: 10.2147/CMAR.S277113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Aramini B, Masciale V, Haider KH. Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective. World J Stem Cells 2020; 12(6): 406-421 [PMID: 32742559 DOI: 10.4252/wjsc.v12.i6.406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Dos Santos Arcas C, Lin-Wang HT, Umeda IIK, de Sousa MG, Utiyama DMO, de Padua Mansur A, Macchione M, Hirata MH, Nakagawa NK. Smoking load reduction is insufficient to downregulate miR-301b, a lung cancer promoter. Sci Rep 2020;10:21112. [PMID: 33273694 DOI: 10.1038/s41598-020-78242-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wu CY, Fu JY, Wu CF, Hsieh MJ, Liu YH, Liu HP, Hsieh JC, Peng YT. Malignancy Prediction Capacity and Possible Prediction Model of Circulating Tumor Cells for Suspicious Pulmonary Lesions. J Pers Med 2021;11:444. [PMID: 34064011 DOI: 10.3390/jpm11060444] [Reference Citation Analysis]
15 Mosharaf MP, Reza MS, Gov E, Mahumud RA, Mollah MNH. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis. Vaccines 2022;10:771. [DOI: 10.3390/vaccines10050771] [Reference Citation Analysis]
16 Chen XR, Zhang YG, Wang Q. miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide. Front Oncol 2021;11:661653. [PMID: 34532283 DOI: 10.3389/fonc.2021.661653] [Reference Citation Analysis]
17 Bai L, Peng X, Sun R. Knockdown of circPRKCA Restrained Cell Growth, Migration, and Invasion of NSCLC Cells Both in vitro and in vivo via Regulating miR-330-5p/PDK1/AKT Pathway. Cancer Manag Res 2020;12:9125-37. [PMID: 33061606 DOI: 10.2147/CMAR.S258370] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hossian AKMN, Zahra FT, Poudel S, Abshire CF, Polk P, Garai J, Zabaleta J, Mikelis CM, Mattheolabakis G. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance. Sci Rep 2021;11:6520. [PMID: 33753779 DOI: 10.1038/s41598-021-85930-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kooshkaki O, Rezaei Z, Rahmati M, Vahedi P, Derakhshani A, Brunetti O, Baghbanzadeh A, Mansoori B, Silvestris N, Baradaran B. MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers. Int J Mol Sci 2020;21:E2578. [PMID: 32276343 DOI: 10.3390/ijms21072578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhu L, Zhang K, Zhang C, Yu H, Zhu L. Low miR-1231 expression predicts poor prognosis in non-small-cell lung cancer and accelerates cell proliferation, migration and invasion. Biomark Med 2021;15:831-40. [PMID: 34223779 DOI: 10.2217/bmm-2020-0313] [Reference Citation Analysis]
21 Qi G, Li L. LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis. Onco Targets Ther 2020;13:6361-71. [PMID: 32669856 DOI: 10.2147/OTT.S238890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Pirlog R, Cismaru A, Nutu A, Berindan-Neagoe I. Field Cancerization in NSCLC: A New Perspective on MicroRNAs in Macrophage Polarization. Int J Mol Sci 2021;22:E746. [PMID: 33451052 DOI: 10.3390/ijms22020746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance. Semin Cancer Biol 2020:S1044-579X(20)30242-X. [PMID: 33220458 DOI: 10.1016/j.semcancer.2020.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yin F, Cai R, Gui S, Zhang Y, Wang X, Zhou N. A portable and quantitative detection of microRNA-21 based on cascade enzymatic reactions with dual signal outputs. Talanta 2021;235:122802. [PMID: 34517660 DOI: 10.1016/j.talanta.2021.122802] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Subramaniyan V, Fuloria S, Gupta G, Kumar DH, Sekar M, Sathasivam KV, Sudhakar K, Alharbi KS, Al-Malki WH, Afzal O, Kazmi I, Al-Abbasi FA, Altamimi ASA, Fuloria NK. A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer. Chem Biol Interact 2021;351:109735. [PMID: 34742684 DOI: 10.1016/j.cbi.2021.109735] [Reference Citation Analysis]
26 Zhou Y, Zhang Y, Li Y, Liu L, Li Z, Liu Y, Xiao Y. MicroRNA-106a-5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK. Exp Ther Med 2021;22:1422. [PMID: 34707704 DOI: 10.3892/etm.2021.10857] [Reference Citation Analysis]
27 Hu Y, Zhang X, Gong C, Li J. Aberrant expression of miR-4728 in patients with non-small cell lung cancer and its regulatory effects on tumor progression in tumor cells. Exp Ther Med 2020;20:15. [PMID: 32934680 DOI: 10.3892/etm.2020.9141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Nguyen VT, Le TTK, Than K, Tran DH. Predicting miRNA-disease associations using improved random walk with restart and integrating multiple similarities. Sci Rep 2021;11:21071. [PMID: 34702958 DOI: 10.1038/s41598-021-00677-w] [Reference Citation Analysis]
29 Xue Y, Zhang J, Hou J, Wang X, Ding X. EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/4402536] [Reference Citation Analysis]
30 Wang XJ, Gao J, Wang Z, Yu Q. Identification of a Potentially Functional microRNA-mRNA Regulatory Network in Lung Adenocarcinoma Using a Bioinformatics Analysis. Front Cell Dev Biol 2021;9:641840. [PMID: 33681226 DOI: 10.3389/fcell.2021.641840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Doghish AS, Elsisi AM, Amin AI, Abulsoud AI. Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome. Can J Diabetes 2021:S1499-2671(20)30486-X. [PMID: 33582040 DOI: 10.1016/j.jcjd.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 de Miguel-Pérez D, Bayarri-Lara CI, Ortega FG, Russo A, Moyano Rodriguez MJ, Alvarez-Cubero MJ, Maza Serrano E, Lorente JA, Rolfo C, Serrano MJ. Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma. Cancers (Basel) 2019;11:E1750. [PMID: 31703465 DOI: 10.3390/cancers11111750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
33 Miao Y, Lu J, Fan B, Sun L. MicroRNA-126-5p Inhibits the Migration of Breast Cancer Cells by Directly Targeting CNOT7. Technol Cancer Res Treat 2020;19:1533033820977545. [PMID: 33256566 DOI: 10.1177/1533033820977545] [Reference Citation Analysis]
34 Zhang R, Shang L, Nan J, Niu K, Dai J, Jin X, Zhang X. Circ-METTL15 contributes to the proliferation, metastasis, immune escape and restrains apoptosis in lung cancer by regulating miR-1299/PDL1 axis. Autoimmunity 2021;:1-13. [PMID: 34796777 DOI: 10.1080/08916934.2021.2001801] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Li C, Wu A, Song K, Gao J, Huang E, Bai Y, Liu X. Identifying Putative Causal Links between MicroRNAs and Severe COVID-19 Using Mendelian Randomization. Cells 2021;10:3504. [PMID: 34944012 DOI: 10.3390/cells10123504] [Reference Citation Analysis]
36 Luo J, Jin Y, Li M, Dong L. Tumor suppressor miR‑613 induces cisplatin sensitivity in non‑small cell lung cancer cells by targeting GJA1. Mol Med Rep 2021;23:385. [PMID: 33760215 DOI: 10.3892/mmr.2021.12024] [Reference Citation Analysis]
37 Shi J, Yang F, Zhou N, Jiang Y, Zhao Y, Zhu J, Prelaj A, Malhotra J, Normanno N, Danese E, Cardona AF, Hong X, Jiang G, Song X. Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development. Transl Lung Cancer Res 2021;10:1444-56. [PMID: 33889521 DOI: 10.21037/tlcr-21-219] [Reference Citation Analysis]
38 MacDonagh L, Gallagher MF, Ffrench B, Gasch C, Gray SG, Reidy M, Nicholson S, Leonard N, Ryan R, Young V, O'Leary JJ, Cuffe S, Finn SP, O'Byrne KJ, Barr MP. MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer. Transl Lung Cancer Res 2021;10:1773-91. [PMID: 34012792 DOI: 10.21037/tlcr-20-959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lai XN, Li J, Tang LB, Chen WT, Zhang L, Xiong LX. MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer. Int J Mol Sci 2020;21:E1193. [PMID: 32054031 DOI: 10.3390/ijms21041193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
40 Sp N, Kang DY, Jo ES, Lee JM, Bae SW, Jang KJ. Pivotal Role of Iron Homeostasis in the Induction of Mitochondrial Apoptosis by 6-Gingerol Through PTEN Regulated PD-L1 Expression in Embryonic Cancer Cells. Front Oncol 2021;11:781720. [PMID: 34804985 DOI: 10.3389/fonc.2021.781720] [Reference Citation Analysis]
41 Sun J, Jia J, Yuan W, Liu S, Wang W, Ge L, Ge L, Liu XJ. LncRNA BLACAT1 Accelerates Non-small Cell Lung Cancer Through Up-Regulating the Activation of Sonic Hedgehog Pathway. Front Oncol 2021;11:625253. [PMID: 33937028 DOI: 10.3389/fonc.2021.625253] [Reference Citation Analysis]
42 Pothipor C, Jakmunee J, Bamrungsap S, Ounnunkad K. An electrochemical biosensor for simultaneous detection of breast cancer clinically related microRNAs based on a gold nanoparticles/graphene quantum dots/graphene oxide film. Analyst 2021;146:4000-9. [PMID: 34013303 DOI: 10.1039/d1an00436k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
43 Qin Y, Wang Y, Zhao H, Yang Z, Kang Y. Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation. Ann Transl Med 2021;9:1405. [PMID: 34733957 DOI: 10.21037/atm-21-1288] [Reference Citation Analysis]
44 Wang D, Zhang S, Zhao M, Chen F. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis. Cancer Med 2020;9:9138-49. [PMID: 33146951 DOI: 10.1002/cam4.3570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
45 Bu L, Tian Y, Wen H, Jia W, Yang S. miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2. Acta Biochim Biophys Sin (Shanghai) 2021;53:189-200. [PMID: 33332541 DOI: 10.1093/abbs/gmaa159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Souza CP, Cinegaglia NC, Felix TF, Evangelista AF, Oliveira RA, Hasimoto EN, Cataneo DC, Cataneo AJM, Scapulatempo Neto C, Viana CR, Paula FE, Drigo SA, Carvalho RF, Marques MMC, Reis RM, Reis PP. Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways. Cancers (Basel) 2020;12:E2711. [PMID: 32971741 DOI: 10.3390/cancers12092711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 He X, Xue N, Liu X, Tang X, Peng S, Qu Y, Jiang L, Xu Q, Liu W, Chen S. A novel clinical model for predicting malignancy of solitary pulmonary nodules: a multicenter study in chinese population. Cancer Cell Int 2021;21:115. [PMID: 33596917 DOI: 10.1186/s12935-021-01810-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Šutić M, Vukić A, Baranašić J, Försti A, Džubur F, Samaržija M, Jakopović M, Brčić L, Knežević J. Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management. J Pers Med 2021;11:1102. [PMID: 34834454 DOI: 10.3390/jpm11111102] [Reference Citation Analysis]
49 Gupta S, Hashimoto RF. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer. Biomolecules 2022;12:420. [DOI: 10.3390/biom12030420] [Reference Citation Analysis]
50 Dai Q, Wang Z, Liu Z, Duan X, Song J, Guo M. Predicting miRNA-disease associations using an ensemble learning framework with resampling method. Brief Bioinform 2021:bbab543. [PMID: 34929742 DOI: 10.1093/bib/bbab543] [Reference Citation Analysis]
51 Kirave P, Gondaliya P, Kulkarni B, Rawal R, Garg R, Jain A, Kalia K. Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition. Oncotarget 2020;11:1157-71. [PMID: 32284792 DOI: 10.18632/oncotarget.27531] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
52 Liao H, Liang Y, Kang L, Xiao Y, Yu T, Wan R. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2. Oncol Rep 2021;45:67. [PMID: 33760169 DOI: 10.3892/or.2021.8018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Guerriero I, Monaco G, Coppola V, Orlacchio A. Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy. Pharmaceuticals (Basel) 2020;13:E413. [PMID: 33266470 DOI: 10.3390/ph13110413] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Geng G, Liu X, Xu A, Lu Z, Chen K, He J, Qi D, Yuan X. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer. J Gene Med 2020;22:e3166. [PMID: 31984574 DOI: 10.1002/jgm.3166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
55 Ma Z, Chen G, Chen Y, Guo Z, Chai H, Tang Y, Zheng L, Wei K, Pan C, Ma Z, Xia Y, Zhang A. MiR-937-3p promotes metastasis and angiogenesis and is activated by MYC in lung adenocarcinoma. Cancer Cell Int 2022;22:31. [PMID: 35033084 DOI: 10.1186/s12935-022-02453-w] [Reference Citation Analysis]
56 Tito C, De Falco E, Rosa P, Iaiza A, Fazi F, Petrozza V, Calogero A. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma. Genes (Basel) 2021;12:1154. [PMID: 34440329 DOI: 10.3390/genes12081154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Musial C, Zaucha R, Kuban-Jankowska A, Konieczna L, Belka M, Marino Gammazza A, Baczek T, Cappello F, Wozniak M, Gorska-Ponikowska M. Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung Cancer. Int J Environ Res Public Health 2021;18:E648. [PMID: 33466597 DOI: 10.3390/ijerph18020648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Kabzinski J, Maczynska M, Majsterek I. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. Biomolecules 2021;11:844. [PMID: 34198889 DOI: 10.3390/biom11060844] [Reference Citation Analysis]
59 Wu Y, Li Q, Zhang R, Dai X, Chen W, Xing D. Circulating microRNAs: Biomarkers of disease. Clin Chim Acta 2021;516:46-54. [PMID: 33485903 DOI: 10.1016/j.cca.2021.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
60 Zhou N, Zhou M, Ding N, Li Q, Ren G. An 11-Gene Signature Risk-Prediction Model Based on Prognosis-Related miRNAs and Their Target Genes in Lung Adenocarcinoma. Front Oncol 2021;11:726742. [PMID: 34804921 DOI: 10.3389/fonc.2021.726742] [Reference Citation Analysis]
61 Li L, Chen J, Wang Y, Zhou C, Ma X, Fu J, Yao B, Zhao P. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells. Toxicology 2020;442:152539. [PMID: 32681969 DOI: 10.1016/j.tox.2020.152539] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Zhou J, Cui X, Xiao F, Cai G. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers. Int J Mol Sci 2021;22:1529. [PMID: 33546390 DOI: 10.3390/ijms22041529] [Reference Citation Analysis]
63 Hussen BM, Ahmadi G, Marzban H, Fard Azar ME, Sorayyayi S, Karampour R, Nahand JS, Hidayat HJ, Moghoofei M. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. Microb Pathog 2021;150:104692. [PMID: 33301856 DOI: 10.1016/j.micpath.2020.104692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Liu Q, Cao G, Wan Y, Xu C, He Y, Li G. Hsa_circ_0001073 targets miR-626/LIFR axis to inhibit lung cancer progression. Environ Toxicol 2021;36:1052-60. [PMID: 33475233 DOI: 10.1002/tox.23104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Noguchi S, Inoue M, Ichikawa T, Kurozumi K, Matsumoto Y, Nakamoto Y, Akiyoshi H, Kamishina H. The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma. Exp Cell Res 2021;400:112504. [PMID: 33508276 DOI: 10.1016/j.yexcr.2021.112504] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Fotoh DS, Noreldin RI, Rizk MS, Elsabaawy MM, Esaily HA. miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes. J Immunol Res 2020;2020:2180913. [PMID: 33426087 DOI: 10.1155/2020/2180913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Liu H, Liu R, Hao M, Zhao X, Li C. Kinesin family member 3C (KIF3C) is a novel non-small cell lung cancer (NSCLC) oncogene whose expression is modulated by microRNA-150-5p (miR-150-5p) and microRNA-186-3p (miR-186-3p). Bioengineered 2021;12:3077-88. [PMID: 34193018 DOI: 10.1080/21655979.2021.1942768] [Reference Citation Analysis]
68 Wu B, Xue X, Lin S, Tan X, Shen G. LncRNA LINC00115 facilitates lung cancer progression through miR-607/ITGB1 pathway. Environ Toxicol 2021. [PMID: 34643030 DOI: 10.1002/tox.23367] [Reference Citation Analysis]
69 Lee SB, Park YS, Sung JS, Lee JW, Kim B, Kim YH. Tumor Suppressor miR-584-5p Inhibits Migration and Invasion in Smoking Related Non-Small Cell Lung Cancer Cells by Targeting YKT6. Cancers (Basel) 2021;13:1159. [PMID: 33800298 DOI: 10.3390/cancers13051159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Mizuno K, Tanigawa K, Nohata N, Misono S, Okada R, Asai S, Moriya S, Suetsugu T, Inoue H, Seki N. FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p). Cells 2020;9:E2083. [PMID: 32932948 DOI: 10.3390/cells9092083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Sp N, Kang DY, Jo ES, Lee JM, Jang KJ. Iron Metabolism as a Potential Mechanism for Inducing TRAIL-Mediated Extrinsic Apoptosis Using Methylsulfonylmethane in Embryonic Cancer Stem Cells. Cells 2021;10:2847. [PMID: 34831070 DOI: 10.3390/cells10112847] [Reference Citation Analysis]
72 Hsieh FM, Lai ST, Wu MF, Lin CC. Identification and Elucidation of the Protective isomiRs in Lung Cancer Patient Prognosis. Front Genet 2021;12:702695. [PMID: 34589114 DOI: 10.3389/fgene.2021.702695] [Reference Citation Analysis]
73 Kan CFK, Unis GD, Li LZ, Gunn S, Li L, Soyer HP, Stark MS. Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low-Dose Computed Tomography. Front Oncol 2021;11:555331. [PMID: 33968710 DOI: 10.3389/fonc.2021.555331] [Reference Citation Analysis]
74 Sodagar H, Alipour S, Hassani S, Aziz SG, Ansari MHK, Asghari R. The role of microRNAs in COVID-19 with a focus on miR-200c. J Circ Biomark 2022;11:14-23. [PMID: 35356072 DOI: 10.33393/jcb.2022.2356] [Reference Citation Analysis]
75 Rubin JB, Lagas JS, Broestl L, Sponagel J, Rockwell N, Rhee G, Rosen SF, Chen S, Klein RS, Imoukhuede P, Luo J. Sex differences in cancer mechanisms. Biol Sex Differ 2020;11:17. [PMID: 32295632 DOI: 10.1186/s13293-020-00291-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
76 Fu J, Li T, Jiang X, Xia B, Hu L. MicroRNA-199-3p targets Sp1 transcription factor to regulate proliferation and epithelial to mesenchymal transition of human lung cancer cells. 3 Biotech 2021;11:352. [PMID: 34249593 DOI: 10.1007/s13205-021-02881-x] [Reference Citation Analysis]
77 Liu S, Li B, Xu J, Hu S, Zhan N, Wang H, Gao C, Li J, Xu X. SOD1 Promotes Cell Proliferation and Metastasis in Non-small Cell Lung Cancer via an miR-409-3p/SOD1/SETDB1 Epigenetic Regulatory Feedforward Loop. Front Cell Dev Biol 2020;8:213. [PMID: 32391354 DOI: 10.3389/fcell.2020.00213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
78 Bersimbaev R, Bulgakova O, Aripova A, Kussainova A, Ilderbayev O. Role of microRNAs in Lung Carcinogenesis Induced by Asbestos. J Pers Med 2021;11:97. [PMID: 33546236 DOI: 10.3390/jpm11020097] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Sun D, Wu Y, Zhang S, Han Y, Shen J, Zheng W, Wei L, Liu Y, Ren L, Gu Z, Liu Y, Liu S, Ding C. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma. Biomed Pharmacother 2021;142:111967. [PMID: 34467896 DOI: 10.1016/j.biopha.2021.111967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Yao D, Zhan X, Kwoh CK. An improved random forest-based computational model for predicting novel miRNA-disease associations. BMC Bioinformatics 2019;20:624. [PMID: 31795954 DOI: 10.1186/s12859-019-3290-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
81 Du X, Wang S, Liu X, He T, Lin X, Wu S, Wang D, Li J, Huang W, Yang H. MiR-1307-5p targeting TRAF3 upregulates the MAPK/NF-κB pathway and promotes lung adenocarcinoma proliferation. Cancer Cell Int 2020;20:502. [PMID: 33061854 DOI: 10.1186/s12935-020-01595-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
82 Noguchi S, Ogusu R, Wada Y, Matsuyama S, Mori T. PTEN, A Target of Microrna-374b, Contributes to the Radiosensitivity of Canine Oral Melanoma Cells. Int J Mol Sci 2019;20:E4631. [PMID: 31540513 DOI: 10.3390/ijms20184631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
83 Santoni-Rugiu E, Melchior LC, Urbanska EM, Jakobsen JN, Stricker K, Grauslund M, Sørensen JB. Intrinsic resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance. Cancers (Basel) 2019;11:E923. [PMID: 31266248 DOI: 10.3390/cancers11070923] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 15.7] [Reference Citation Analysis]
84 Sp N, Kang DY, Lee JM, Jang KJ. Mechanistic Insights of Anti-Immune Evasion by Nobiletin through Regulating miR-197/STAT3/PD-L1 Signaling in Non-Small Cell Lung Cancer (NSCLC) Cells. Int J Mol Sci 2021;22:9843. [PMID: 34576006 DOI: 10.3390/ijms22189843] [Reference Citation Analysis]
85 Pozza DH, De Mello RA, Araujo RLC, Velcheti V. MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice? Curr Genomics 2020;21:372-81. [PMID: 33093800 DOI: 10.2174/1389202921999200630144712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]